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Abstract
Introduction: Sternal wound infection caused by Mycobacterium chelonae, a member of rapidly
growing non-tuberculous mycobacteria, is rare and may present without signs and symptoms of
systemic infection.
Methods: We present a patient who had a Mycobacterium chelonae infection of the sternum
following excision of a left atrial myxoma and conducted a review of the literature from 1976 to
2013.
Results: 70 cases of NTM sternal wound infection after cardiac surgery was identified, including
6 outbreaks and 10 sporadic cases including the present case.

34 cases were isolated coronary

artery bypass grafting surgery (CABG), 16 cases were isolated valve replacement and 2 cases
were valve replacement with CABG. The age range of the patients was between 6 and 78 years.
The average time from the surgery was 49 ± 58 days which was longer than usual bacterial
mediastinitis.

The overall mortality rate was 29%.

Conclusion: NTM sternal wound infection is rare but may be fatal if not properly treated. The
toxic signs are often subtle and it will take longer to isolate compared to typical bacterial
mediastinitis.

Early recognition, the use of appropriate antibiotics based on susceptibility tests

and aggressive surgical debridement is required for full recovery.

(Word count of abstract:

197)

Key words: cardiac surgery, mediastinitis, mycobacterium, surgical site infection, acid fast
bacilli

3

Introduction
Sternal wound infection has remained one of the most devastating complications of
cardiac surgery with its incidence of 1-3%.1
group and gram-negative bacilli.1
cephalosporins.2, 3
cephalosporins.4

The most common organisms are Staphylococci

Therefore, standard prophylactic antibiotics are

However, most non-tuberculous mycobacteria (NTM) are not sensitive to
We report a case of Mycobacterium chelonae infection of the sternum

following excision of a left atrial myxoma in a 60-year-old man. This case report illustrates the
unique clinical presentation and the treatment for NTM sternal wound infection and would alert
clinicians that NTM may be a cause of culture negative sternal wound infection.
Case Report
A 60-year-old male with a past medical history of hypertension, hyperlipidemia and
multiple episodes of right lower lobe pneumonia secondary to chronic aspiration was found to
have a left atrial myxoma (4 x 2.5cm). He underwent excision of the myxoma, which was
complicated by postoperative bleeding and tamponade requiring re-exploration on postoperative
day 0.

Otherwise, he had an uneventful hospital course and he was discharged to a

rehabilitation facility on postoperative day 7. Three months later, on a scheduled office visit,
there was serosanguinous drainage from the sternal incision.
malaise or fatigue.

He denied pain, fever, chill,

He was admitted to the hospital with a diagnosis of sternal wound infection.

He was afebrile. Physical examination showed mild serosanguinous drainage from the
mid-sternal incision without erythema or tenderness.

Laboratory data showed white blood cell

count (WBC) 7.6 B/L and procalcitonin 0.11 ng/ml. Chest CT (Figure 1) showed a sub-sternal
fluid collection with sternal dehiscence. He was scheduled for a wound exploration and
drainage in the operating room.

Antibiotics were not started until the operative exploration due
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to his stable condition.

His sternal incision was opened, all the wires were removed, and the

wound was closed with a vacuum assisted closing device.

The gram stain and acid-fast stain of

the drainage and tissue obtained in the operating room showed no organisms.

The culture

initially showed very light growth of coagulase negative staphylococcus and propionibacterium
acnes; thus, vancomycin was started. However, 5 days later, the culture turned positive for
acid-fast organism.

Antibiotic regimens were modified to tobramycin, imipenem, moxifloxacin

and clarithromycin, in addition to vancomycin.

He underwent a total sternectomy on

postoperative day 6 and his chest was closed on postoperative day 12 with a pectoralis major
muscle flaps.

The specimen was sent to FOCUS Diagnostics (Cypress, CA) for further

speciation and susceptibility testing, and the organism was later identified as Mycobacterium
chelonae.

The antibiotics were changed to tigecycline and clarithromycin based on the

sensitivity. Tigecycline was continued for 2 weeks.

He was discharged on postoperative day

32 on oral clarithromycin, which was continued for 6 months.

He is currently being followed as

an outpatient without relapse for 1 year.
Discussion
Bacteriology:

Mycobacterium chelonae is one of the species of rapidly growing NTM (RGM).

The most common strains among RGM are Mycobacterium fortuitum, Mycobacterium abscessus
and Mycobacterium chelonae.5

NTM is ubiquitous in the environment and has been isolated

from house dust, raw and pasteurized milk, fish, cattle, soil and various water related sources,
including water in hospital tanks as well as scrub sinks in operating room.2, 6, 7
isolated from sputum and saliva of healthy adult humans.7

They have been

Some NTM strains are resistant to

the commonly used disinfectants such as organomercurials, chlorine, formaldehyde, and alkaline
glutaraldehyde.8
Lung infection, post-traumatic wound infection, post surgical wound infection, and
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catheter related infection are the common clinical manifestations caused by NTM.9

NTM was

also reported to be the pathogen of meningitis, peritonitis, salpingitis, prostatitis and
epididymitis.7

In cardiac surgery, 25 Hancock porcine valves implanted at ten medical centers

were contaminated by M. chelonei subspecies chelonei in 1976-77.10, 11

These valves were

found to be contaminated during the harvesting process from pigs,12 and the organism was
relatively resistance to 2% formaldehyde which was used for valve sterilization.10, 13, 14

Two of

the 24 patients (1 patient received 2 valves) developed mycobacterium infection; mycobacterial
pericarditis and aortic root abscess.10

Few cases of isolated native valve endocarditis caused by

M. abscessus are reported as well.15-17
To the best of our knowledge, a total of 70 cases of NTM sternal wound infection after
cardiac surgery were reported, including 6 outbreaks in the 1970s -1980s and 10 sporadic cases
including the present case (Table 1).
sternal wound infections were RGM.
abscessus, and M. peregrinum.

Interestingly, all of the NTMs that were isolated from
M. fortuitum was isolated in most cases, followed by M.

An isolated case of M.porcinum sternal wound infection was

reported from Spain, and M. smegmatis was submitted to Tyler Mycobacteria / Nocardia
laboratory from sternal wound infection that occurred in Texas and California.18
In 1966, M. fortuitum was divided into three subgroups; biotypes A, B and C, based on
the differences in acid production from carbohydrates.9, 19

In 1974, Pattyn renamed them as M.

fortuitum biovariant fortuitum, M. fortuitum biovariant peregrinum, and an unnamed third
biovariant.9, 20

In early 1990s, based on genomic DNA studies, M. fortuitum biovariant

fortuitum and M. fortuitum biovariant peregrinum were upgraded to species status, M. fortuitum
and M. peregrinum respectively.9, 21, 22

Therefore, “M. fortuitum” infections reported before

1990s may have not accurately separated the subgroups of M. fortuitum.

For example, the

organism isolated in the second outbreak in Colorado was initially reported as “M. fortuitum” but
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was later identified as M. fortuitum biovariant fortuitum.23
Another RGM, M. chelonei was isolated from the lungs of turtles in 1903 by
Friedmann24, and the name was changed to the more correct Latin; M. chelonae in 1984.25
abscessus was identified by Moore and Frerichs in 1953 from a knee abscess.

M.

In the past, M.

abscesses and M. chelonei were believed to be the same organism because they had almost
identical biochemical features.

In 1972, Kubica demonstrated that M. chelonei and M.

abscesses were different and needed to be classified as subspecies. These were renamed as M.
chelonae subspecies chelonae and M. chelonae subspecies abscessus.26

Genomic DNA studies

showed that the two subspecies were different species, and once again, they were renamed as M.
chelonae and M. abscessus in early 1990s.21, 22 Like in the case of M. fortuitum, little effort was
made to differentiate the two species in the reports before 1990.9

The organism that was

isolated in the first outbreak in North Carolina was initially reported to be “M. chelonei” but was
later identified as M. chelonae subspecies abscessus.27

To the best of our knowledge, other than

our report, sternal wound infections caused by M. chelonae (chelonei) have been only reported
once, by Yew in 198828, when M. chelonei and M. abscessus might have not been differentiated.
In most of the reported outbreaks of RGM sternal infection, the source-identification
failed despite extensive workup.

In 1976, Robicsek reported an outbreak of RGM sternal

infections that occurred in 19 of 80 patients who underwent cardiac surgery.29

He cultured

materials used in the operating room such as bone wax, gauze, povidone-iodine, needle and wire,
surgeon’s hair, nose, throat and hands, but was unsuccessful.

In another outbreak, Kuritsky

reported that the water for cooling the cardioplegia solution in the operating room was considered
to be a source of contamination by M. chelonae.30

From an epidemiological point of view, the

fact that the reported outbreaks were caused by different strains, some outbreaks had more than
one strain, the outbreaks occurred in areas of high endemicity of all forms of NTM infection,
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suggests that the outbreaks of NTM infection could be more related to the local environmental
source, rather than a contaminated surgical material.31
Characteristics of NTM Sternal infection:

Among the 70 cases of NTM sternal

infections, 34 cases were isolated coronary artery bypass grafting surgery (CABG), 16 cases were
isolated valve replacement and 2 cases were valve replacement with CABG.
the patients was between 6 and 78 years.

The age range of

The patients were not necessarily

immune-compromised; however, prolonged surgical exposure, the use of cardiopulmonary
bypass, prosthetic material, intravenous and intra-arterial catheters for monitoring and infusion
may increase the risk of nosocomial infections.32 Almost all patients had an uneventful
postoperative course and most of the patients were initially discharged from hospital in a
reasonable time period with stable condition.
Sternal wound infections caused by RGM have unique manifestations compared to
typical bacterial infections.

One of the interesting features of RGM sternal wound infection is

the delayed onset, as in our case.

Although they are categorized as “rapidly growing”

mycobacterium, the growth is slow compared to typical sternal infection organisms, such as
Staphylococcus or gram negative bacilli.
months after the surgery.33
49 ± 58 days.

Chow reported a case whose first symptom started 11

The average time from the surgery based on the available data was

Whereas, typical bacterial sternal mediastinitis is reported to occur between 4 and

30 days, mostly within the first 2 weeks.34
appear to be septic in most cases.29

The patients with RGM sternal infection do not

High fever with elevated WBC is rare in RGM sternal

infection, in contrast to typical bacterial mediastinitis which the patients frequently present with
fever, elevated WBC count, and a septic picture.35, 36

Procalcitonin, a biomarker that increases

in bacterial infection37, was only slightly elevated in our case.

Sternal drainage is the most

common presentation of RGM sternal infection, and in most cases, the drainage was odorless and
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watery rather than purulent.27

Presence of satellite abscesses are also characteristic.2

The

initial aerobic and anaerobic cultures are usually negative, or it may grow normal flora of the skin,
such as staphylococcus epidermidis or corynebacterium species.
MacConckey’s agar but may take up to 7 days to culture.2

RGM grows on blood or

The delay of the isolation may cause

delay in treatment, since the drug sensitivity is different from typical pathogen of sternal wound
infection.7
Antibiotics therapy:

RGM is usually resistant to the first-line antituberculous drugs such as

isoniazid, rifampin, and pyrazinamide.5, 38
based on sensitivity tests.27, 30

In the reported outbreaks, antibiotics were selected

Hoffmann reported the use of kanamycin for 7-10 days, followed

by erythromycin and rifampin. Kuritsky reported the use of amikacin and cefoxitin.
reported the efficacy of oral single daily dose oxacillin therapy.28

Yew

Clarithromycin is currently

the drug of choice for M. chelonae and M. abscessus, because of the excellent tissue penetration,
susceptibility and few side effects.35

Combination therapy is recommended to minimize the

development of drug resistance.35, 39 Recently, linezolid, tigecycline, telithromycin, gatifloxacin
are reported to be effective against RGM.8, 40
fortuitum are susceptible to linezolid.8
susceptibility test is recommended.8

Approximately 50% of M. abscessus, 96% of M.

At least 4 to 6 months of antibiotic treatment based on
In our case, clarithromycin was continued for 6 months.

For sternal infection caused by M. chelonae, one of the injectable agents such as
imipenem, tobramycin was recommended in combination with clarithromycin for at least the first
2 weeks.9

Tobramycin is preferred to amikacin because of its greater in-vitro activity against M.

chelonae.9

Oral agents such as minocycline and doxycycline are effective against only 20% of

M. chelonae.9

Cefoxitin which is used for M. abscessus is uniformly resistant for M. chelonae.8

For sternal infections caused by M. abscessus, amikacin plus cefoxitin or imipenem is
used for the first 2 to 6 weeks in combination with clarithromycin, until clinical improvement is
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evident.8, 9

M. abscessus is usually resistant against tobramycin.4

For the majority of M.

abscessus and M. chelonae isolates, imipenem is the preferred carbapenem over meropenem and
ertapenem.8
Antibiotic therapy against M. fortuitum is much easier than M. abscessus or M. chelonae,
since M. fortuitum is less drug resistant. Amikacin, cefoxitin, imipenem, sulfamethoxazole, and
fluoroquinolones are recommended.9

Amikacin combined with beta-lactam (cefoxitin or

imipenem) or a quinolone is used for initial therapy against serious infection. Yew reported the
use of ofloxacin as a monotherapy41, but the development of mutational resistance resulted in
treatment failure and relapse.9
agent should be used.

Therefore, if a quinolone is used, an additional antimicrobial

80% of M. fortuitum are susceptible to clarithromycin, but recent studies

have shown that all isolates of M. fortuitum contain an erythromycin methylase gene erm, which
may induce macrolide resistance.8
Surgical treatment:

Surgical debridement in conjunction with appropriate antibiotic therapy

is mandatory for complete recovery.

Among the 70 reported cases, almost all cases underwent

extensive drainage and debridement.

All wires should be removed.

If the combination of

surgical debridement and appropriate antibiotics fails to eliminate the infection, more aggressive
approach such as sternectomy combined with a pectoralis flap or omental flap will be required.
Outcomes:

The outcome of the RGM sternal infection is not benign: 14 out of 49 cases died

giving the overall mortality rate of 29%, although 21 cases did not report the outcome.

Of the

14 deaths, 6 cases (75%, 6/8) had valve replacement surgery, 5 cases (19%, 5/26) had CABG,
p=0.003.
and stroke.

The common cause of mortality was prolonged sepsis, prosthetic valve endocarditis,
Robicsek reported that fatal hemorrhage from the aortotomy suture line and

cannulation site, sepsis, prosthetic valve endocarditis resulting in stroke were the cause of 4
deaths in an outbreak in North Carolina.29

Narasimhan reported a case that developed
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mediastinitis 5 weeks after aortic valve replacement.
and subsequently infected the prosthetic valve.
and death.7

In that report, mediastinitis caused sepsis,

Emboli from the vegetation resulted in stroke

Chow reported a case of M. fortuitum superficial sternal wound infection that

occurred 2 months after aortic and mitral valve replacement.

The sternal wound was healed

completely after 4 weeks of ofloxacin treatment; however, the patient was readmitted for
RGM-aortic root abscess 11 months later from the initial procedure and resulted in mortality.33
In valve replacement surgery, prosthetic valves may be a nidus of RGM infection and would
result in prolonged sepsis and endocarditis.

The additional suture lines would be susceptible to

mediastinal infection, which will eventually lead to uncontrollable bleeding, causing a high
mortality rate in valve replacement surgery, compared to CABG.27

If infection of RGM

occurred after valve surgery and if the valve was infected, valve replacement with homograft
should be considered.
Conclusion:

It is possible that many reported cases of culture negative sternal wound

infection may be due to mycobacterial infections, especially if the patient had a delayed onset and
failed to response to standard antibiotic therapy.

The diagnosis may be difficult, because the

toxic signs are often subtle and it will take longer to isolate compared to typical bacteria.
of specific treatment may result in dismal outcomes.

Delay

Early recognition, the use of appropriate

antibiotics based on susceptibility tests and aggressive surgical debridement is required for full
recovery.
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Legends of figures
Figure 1:

CT scan showed substernal fluid collection with sternal dehiscence.
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Table 1: Characteristics of the sternal infection caused by rapidly growing non-tuberculosis mycobacteria.

Reference

Robicsek

Hoffman

Jauregui

Szabo

Year

No. of
cases
(sex)

1976

19
(15 male
and
4 female)

1976

Place

Organism

42-66
(57)

North
Carolina,
USA

M. chelonei
subspecies
abscessus

30-70
(54.5)

Colorado,
USA

M. fortuitum

Michigan,
USA

M. chelonei
subspecies
abscessus

6-44
(25) days

Quality of
drainage

WBC
(median)

Long-term
antibiotics

low grade

no odor,
more
watery
than
purulent

6.9-29.6
(10.3)

erythromycin and
rifampin

NA

thick,
whitish,
cheesy,
brown, or
purulent

7.0-18.5
(9.2)

Outcome

5 deaths

rifampin,
ethambutol, and
isoniazid (4)
all healed
ethionamide
ethambutol, and
isoniazid (1)

yellowish,
white

9.4

erythromycin and
vancomycin

11-45
days

fever (5)
no fever (1)

serous,
containing
yellowish
fragment,
odorless

normal

NA

3 deaths

M. fortuitum

5 weeks

38.5°C

NA

4.8

ethinamide,
isoniazid, and
rifampin

1 death

M. fortuitum

NA

NA

NA

NA

NA

1 death

1977

6
(sex
unknown)

NA

Hungary

M. chelonei
subspecies
abscessus

1
(male)

57

Canada
(Ontario)

5
(sex
unknown)

NA

Nebraska,
USA

1981

6-40
(14) days

Fever

38°C

1
(male)

55

Duration
after
surgery
(median)

death
(bleeding
from
anastomo
sis)

1977

Narasimhan 1978

Preheim
(reference
Brown-Ell
iott 2002)

5
(3 male
and 2
female)

Age
range
(median)

61 days
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Kuritsky

1981

4
(all male)

49-76
(62.5)

Texas,
USA

M. chelonei
subspecies
abscessus,
M. fortuitum
biovariant
fortuitum

21-92
(26) days

fever (2),
no fever (2)

amikacin and
cefoxitin (2)
NA

NA
amikacin, cefoxitin
and doxycycline (1)

Sethi

1982

1 (male)

61

North
Carolina,
USA

M. fortuitum

30 days

37.8°C

serous,
odorless

Kuhn

1983

1
(male)

56

Indiana

M. fortuitum

28 days

low grade

brown
purulent

0-2
months

NA

NA

NA

NA

4.4

1 death,
3 healed

doxycycline,
sulphamethoxazole,
and ethionamide

1 healed

ciprofloxacin,
erythromycin, and
amikacin

1 death

Yew

1987
1989

21
(13 male
and 8
female)

28-70
(58)

Hong Kong

M. fortuitum
biovariant
fortuitum (7)
M. fortuitum
biovariant
peregrinum (12)
M. fortuitum third
biovariant complex
(2)

Chow

1988

1
(female)

45

Hong Kong

M. fortuitum

11months

NA

NA

NA

oxacillin

1 death

Samuels

1996

1
(female)

49

PA, USA

M. fortuitum

35 days

low grade

watery

NA

ciprofloxacin,
sulfamethoxazole,
and clarithromycin

1 healed

Syed

1997

1
(male)

6

Saudi
Arabia

M. fortuitum

19 days

38.5°C

yellowish,
odorless,
thick pus

amikacin,
sulfamethoxazole
and trimethoprim

1 healed

Idigoras

2003

1
(male)

78

Spain

M. porcinum

6 months

NA

pus

ciprofloxacin

1 healed

NA

NA
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Sarma

2010

1
(male)

75

India

M. abscessus

1 month

No

serosangui
nous

10.4

azithromycin,
amikacin, and
ciprofloxacin

1 healed

Unai

2013

1
(male)

60

PA USA

M. chelonae

3 months

No

serosangui
nous

7.6

tigecycline, and
clarithromycin

1 healed

NA: not available; WBC: white blood cell count (B/L).
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